周儒伦-Stem Cell—Opportunities and Challenges.ppt

* * Confidential * * Confidential * Confidential * Confidential * Confidential * Confidential * Confidential * Confidential * Confidential * Confidential * Confidential * Confidential * Confidential * Confidential Stem Cell—Opportunities and Challenges for Pharmaceutical Industry Rulun Zhou MD MS Director of Beijing Office HUYA Bioscience International Removing Barriers for Human Stem Cells Research President Barack Obama signing an executive order lifting restrictions on embryonic stem cell research Permissive-various embryonic stem cell derivation techniques including somatic cell nuclear transfer (SCNT), also called research or therapeutic cloning. Flexible-derivations from fertility clinic donations only, excluding SCNT, and often under certain restrictions. Restrictive policy or no established policy (Map used by Senator Bingaman on the floor of the U.S. Senate) World Policies for Stem Cell Research Stem Cell Studies—Comparison by Numbers (Data from NIH, Feb 15, 2012) World East Asia Chinese Government Support for Stem-Cell Research And Comparison of 3 Countries Government fund (Million RMB Yuan) Data Source: Chen T et al, Analysis of Stem Cell Research Supporting Model Based on National Basic Research Program of China, China Basic Science, April, 2011, pp.31-35 Fund Scale (Million $) Estimated for 2006-2010 Distribution of Chinese Government Fund Supporting Stem Cell Research Data Source: Chen T et al, Analysis of Stem Cell Research Supporting Model Based on National Basic Research Program of China, China Basic Science, April, 2011, pp.31-35 % of Global total Stem-Cell Papers First-authored by Chinese Domestic Researchers Data source: Chen T, Comparative Analysis of Stem Cell Research and Industry Development between China and Foreign Countries, China Scientific Forum,2011,issue 10, 160 2010 World rank of patent for Stem Cells Application Patent Priority Right No 3 No 6 Fast Growth of Stem Cell Research in China 0.3 7.5 Data source: Fu J and Chen Y, Worl